Table VIII.

Adverse events that occurred during the current study.

Participant Number	Group	Adverse events	Start datea	Date of terminationa	Severity	Intervention	Note	Outcome	Association with the medication
01020	YQGB	Bladder cancer	20120410	20120619	Moderate	Termination	Bladder resection, chemotherapy	Recovery with sequela	No
01021	YQGB	Rhinitis	20120602	20120629	Mild	–	Occurred after intervention	Recovery	No
01081	YQGB	Abdominal pain	20120516	20120604	Moderate	Pause	Diet of raw or cold food	Resolved	No
01092	Pb	Renal calculus	20120716	20120724	Moderate	Pause		Recovery	No
01100	YQGB	Colorectal cancer	20140520	20120913	Moderate	–	Occurred after intervention	Unresolved	No
01121	Pb	Urticaria	20120918	20120920	Mild	–	Occurred after intervention	Recovery	No
01141	Pb	Cholecystitis	20120825	20120902	Moderate	Pause	Had anamnesis of cholecystitis	Recovery	No
01141	Pb	Gastroenteritis	20121020	20121030	Moderate	Pause	Diet of raw or cold food	Recovery	No
01144	Pb	Agitation	20121011	20121026	Mild	–	Occurred after intervention	Recovery	No
01150	YQGB	Lung cancer	20120717	20120717	Moderate	Termination		Unresolved	No
01155	Pb	Cystitis	20121120	20121130	Mild	–	Occurred after intervention	Recovery	No
01167	YQGB	Dizziness	20120904	20120919	Moderate	Pause	Had anamnesis of cerebral ischemia	Recovery	No

YQGB, Yiqigubiao pill; Pb, placebo.

^aDate presented in the format yyyymmdd.